(Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | (Q3)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -677.63%-507.33K | 69.90%-206.72K | 99.27%-107.11K | 373.04%2.19M | 76.76%-1.55M | 98.97%-65.24K | 29.30%-686.68K | 4.36%-14.77M | 34.01%-802.89K | -10.49%-6.66M |
Net income from continuing operations | -115.13%-599.17K | 46.17%-665K | 84.68%-2.8M | -160.40%-3.92M | 65.37%-1.6M | 137.77%3.96M | 25.25%-1.24M | 3.30%-18.27M | 48.40%-1.51M | 30.29%-4.63M |
Operating gains losses | 101.60%49.41K | -31.60%30.57K | -678.45%-2.32M | 1,270.81%526.46K | -61.22%192.71K | -2,760.05%-3.08M | -21.58%44.68K | 460.60%401.11K | ---44.97K | --496.93K |
Depreciation and amortization | 22.09%10.68K | 22.05%10.68K | 22.76%38.88K | 34.10%10.69K | 34.10%10.69K | 9.77%8.75K | 12.80%8.75K | 100.60%31.67K | 104.07%7.97K | 99.85%7.97K |
Asset impairment expenditure | ---- | ---- | --3.33M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Remuneration paid in stock | --0 | -49.64%372.13K | -71.59%973.04K | --0 | 3,053.21%201.36K | -99.04%32.71K | --738.97K | 393.00%3.43M | --0 | -91.71%6.39K |
Other non cashItems | -14.75%1.17K | -14.68%1.17K | -98.27%5.5K | -99.93%1.38K | -98.72%1.38K | 100.08%1.38K | -87.76%1.38K | 127.14%317.63K | -29.39%1.9M | 108.67%107.62K |
Change In working capital | 103.11%30.58K | 117.84%43.72K | 197.83%662.42K | 293.64%2.24M | 86.75%-351.33K | -138.91%-983.1K | -140.47%-245.06K | 13.47%-677.1K | -202.19%-1.16M | -102.28%-2.65M |
-Change in receivables | 104.29%89.76K | -777.30%-39.74K | 180.20%548.94K | 265.57%1.64M | 571.49%998.52K | -483.46%-2.09M | -98.86%5.87K | 7.02%-684.45K | -402.77%-988.87K | 153.63%148.7K |
-Change in prepaid assets | 55.72%-86.46K | 108.23%16.11K | 2.33%138.07K | 1,492.33%383.59K | -63.32%145.47K | -702.37%-195.27K | 25.14%-195.72K | -66.11%134.93K | 106.51%24.09K | 12.72%396.63K |
-Change in payables and accrued expense | -97.91%27.28K | 222.00%67.36K | 80.72%-24.6K | 214.53%221.05K | 53.23%-1.5M | --1.3M | ---55.21K | 71.30%-127.58K | -205.01%-193.01K | -130.76%-3.2M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -677.63%-507.33K | 69.90%-206.72K | 99.27%-107.11K | 373.04%2.19M | 76.76%-1.55M | 98.97%-65.24K | 29.30%-686.68K | 4.36%-14.77M | 34.01%-802.89K | -10.49%-6.66M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 18.02%-77.51K | 0 | -93.02%-94.55K | 0 | 0 | |||||
Net PPE purchase and sale | ---- | ---- | 18.02%-77.51K | --0 | ---- | ---- | ---- | -93.02%-94.55K | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | ---- | 18.02%-77.51K | --0 | ---- | ---- | ---- | -93.02%-94.55K | --0 | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 0 | 797.77%17.01M | 0 | -72.28%117.5K | |||||
Net common stock issuance | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --7M | --0 | --0 |
Proceeds from stock option exercised by employees | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 434.38%10.13M | --0 | -72.28%117.5K |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---114.12K | --0 | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 797.77%17.01M | --0 | -72.28%117.5K |
Net cash flow | ||||||||||
Beginning cash position | 12.63%2.63M | -6.10%2.84M | 245.18%3.02M | -83.08%647.71K | -78.08%2.27M | -72.85%2.34M | 245.18%3.02M | -93.95%876.22K | 147.63%3.83M | 45.02%10.37M |
Current changes in cash | -677.63%-507.33K | 69.90%-206.72K | -108.59%-184.63K | 373.04%2.19M | 75.16%-1.62M | -103.71%-65.24K | -108.88%-686.68K | 115.80%2.15M | -19.94%-802.89K | -16.72%-6.54M |
End cash Position | -6.46%2.13M | 12.63%2.63M | -6.10%2.84M | -6.10%2.84M | -83.08%647.71K | -78.08%2.27M | -72.85%2.34M | 245.18%3.02M | 245.18%3.02M | 147.63%3.83M |
Free cash from | -677.63%-507.33K | 69.90%-206.72K | 98.76%-184.63K | 373.04%2.19M | 75.60%-1.62M | 98.97%-65.24K | 35.05%-686.68K | 4.05%-14.86M | 36.48%-802.89K | -10.46%-6.66M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data